UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Substrate stiffness and the receptor-type tyrosine-protein phosphatase alpha regulate spreading of colon cancer cells through cytoskeletal contractility

Oncogene, 2010-05, Vol.29 (18), p.2724-2738

2010

Volltextzugriff (PDF)

Palliative Therapie des Pankreaskarzinoms

Deutsche medizinische Wochenschrift, 2007-04, Vol.132 (15), p.813-817

2007

Volltextzugriff (PDF)

Palliative treatment of pancreatic cancer

Deutsche medizinische Wochenschrift, 2007-04, Vol.132 (15), p.813

2007

Volltextzugriff (PDF)

CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation

Oncogene, 2007-08, Vol.26 (40), p.5939-5949

2007

Volltextzugriff (PDF)

Force-dependent integrin-cytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2

The EMBO journal, 2003-10, Vol.22 (19), p.5023-5035

2003

Volltextzugriff (PDF)

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

British journal of cancer, 2013-09, Vol.109 (6), p.1408-1413

2013

Volltextzugriff (PDF)

Belastungsdyspnoe, Myalgien und Petechien der unteren Extremitäten sowie ausgeprägte Gingivitis bei einer 64-jährigen Patientin

Der Internist (Berlin), 2020-02, Vol.61 (2), p.213-216

2020

Volltextzugriff (PDF)

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

The lancet oncology, 2013-05, Vol.14 (6), p.490-499

2013

Volltextzugriff (PDF)

Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo

The Journal of clinical investigation, 2007-06, Vol.117 (6), p.1502-1513

2007

Volltextzugriff (PDF)

Exertional dyspnea, myalgia, petechiae of the lower extremities and pronounced gingivitis in a 64-year-old female patient

Der Internist (Berlin), 2020-02, Vol.61 (2), p.213-216

2020

Volltextzugriff (PDF)

Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells

Nature cell biology, 2003-09, Vol.5 (9), p.803-811

2003

Volltextzugriff (PDF)

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555)

BMC cancer, 2012-04, Vol.12 (1), p.142-142, Article 142

2012

Volltextzugriff (PDF)

Adjuvante Chemotherapie bei soliden Tumoren des Gastrointestinaltrakts: Sind Fortschritte zu erkennen?

Der Internist (Berlin), 2007-12, Vol.48 (12), p.1335-1342

2007

Volltextzugriff (PDF)

1259 Trabedersen (AP 12009) in the treatment of pancreatic carcinoma and other malignant tumors: interim results of the Phase I/II study

European journal of cancer supplements, 2009, Vol.7 (2), p.138-138

2009

Volltextzugriff (PDF)

Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling

Molecular biology of the cell, 2005-09, Vol.16 (9), p.4375-4385

2005

Volltextzugriff (PDF)

Regulation of cyclin D1 expression by autocrine IGF-I in human BON neuroendocrine tumour cells

Oncogene, 2005-02, Vol.24 (7), p.1284-1289

2005

Volltextzugriff (PDF)

Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (16), p.4573-4581

2000

Volltextzugriff (PDF)

31-jährige Schwangere mit refraktärer Hyperkalzämie

Der Internist (Berlin), 2012-12, Vol.53 (12), p.1490-1495

2012

Volltextzugriff (PDF)

Epidermal growth factor activates nuclear factor-κB in human proximal tubule cells

American journal of physiology. Renal physiology, 2005-10, Vol.289 (4), p.F808-F815

2005

Volltextzugriff (PDF)

Protein kinase D2 regulates chromogranin A secretion in human BON neuroendocrine tumour cells

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.22165-22165

2008

Volltextzugriff (PDF)

A 31-year-old pregnant woman with refractory hypercalcemia

Der Internist (Berlin), 2012-12, Vol.53 (12), p.1490-1495

2012

Volltextzugriff (PDF)

Trabedersen (AP 12009) in the treatment of patients with advanced tumors: Completion of dose-escalation and first efficacy data

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.2611-2611

2010

Volltextzugriff (PDF)

Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2513-2513

2011

Volltextzugriff (PDF)

Phase I/II trial of capecitabine (Cap) and oxaliplatin (Ox) in combination with bevacizumab (Bev) and imatinib (Ima) in patients with metastatic colorectal cancer (CRC): AIO KRK 0205

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3583-3583

2011

Volltextzugriff (PDF)

Interim results of the phase I/II study of trabedersen (AP 12009) in patients with pancreatic carcinoma, malignant melanoma, or colorectal carcinoma

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.4619-4619

2009

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(55)
Deutsch
(55)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(47)
Science & Technology
(39)
Life Sciences & Biomedicine
(31)
Female
(21)
Male
(20)
Middle Aged
(17)
Biological And Medical Sciences
(13)
Adult
(12)
Medical Sciences
(11)
Aged
(10)
Animals
(9)
Oncology
(8)
Technology
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Automation & Control Systems
(6)
Cell Biology
(6)
Engineering
(6)
Engineering, Electrical & Electronic
(6)
General & Internal Medicine
(6)
Medicine, General & Internal
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Substrate stiffness and the receptor-type tyrosine-protein phosphatase alpha regulate spreading of colon cancer cells through cytoskeletal contractility

Palliative Therapie des Pankreaskarzinoms

Palliative treatment of pancreatic cancer

CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation

Force-dependent integrin-cytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

Belastungsdyspnoe, Myalgien und Petechien der unteren Extremitäten sowie ausgeprägte Gingivitis bei einer 64-jährigen Patientin

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo

Exertional dyspnea, myalgia, petechiae of the lower extremities and pronounced gingivitis in a 64-year-old female patient

Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555)

Adjuvante Chemotherapie bei soliden Tumoren des Gastrointestinaltrakts: Sind Fortschritte zu erkennen?

1259 Trabedersen (AP 12009) in the treatment of pancreatic carcinoma and other malignant tumors: interim results of the Phase I/II study

Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling

Regulation of cyclin D1 expression by autocrine IGF-I in human BON neuroendocrine tumour cells

Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells

31-jährige Schwangere mit refraktärer Hyperkalzämie

Epidermal growth factor activates nuclear factor-κB in human proximal tubule cells

Protein kinase D2 regulates chromogranin A secretion in human BON neuroendocrine tumour cells

A 31-year-old pregnant woman with refractory hypercalcemia

Trabedersen (AP 12009) in the treatment of patients with advanced tumors: Completion of dose-escalation and first efficacy data

Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma

Phase I/II trial of capecitabine (Cap) and oxaliplatin (Ox) in combination with bevacizumab (Bev) and imatinib (Ima) in patients with metastatic colorectal cancer (CRC): AIO KRK 0205

Interim results of the phase I/II study of trabedersen (AP 12009) in patients with pancreatic carcinoma, malignant melanoma, or colorectal carcinoma

Suchergebnisse filtern